+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biodegradable Stents: Global Markets

  • ID: 4761513
  • Report
  • Region: Global
  • 102 pages
  • BCC Research
1 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc.
  • Amg International Gmbh
  • Boston Scientific Corp.
  • Ella-Cs S.R.O.
  • Lifetech Scientific Corp.
  • Micell Technologies Inc.
  • MORE
Report Scope:

This report reviews both global and regional markets of the biodegradable stents market according to available types and application areas. The report analyzes the current market status and trends, and provides growth forecasts for the five-year period 2018 to 2023. The analysis also discusses R&D issues, including global regulatory scenarios and other commercialization hurdles. Additionally, this comprehensive report examines technology developers/manufacturers of biodegradable stents, their product types and geographical product presence (wherever data is available).

The biodegradable stents market is divided into the following types
  • Polymer-based.
  • Metal-based.
The report differentiates BDS from conventional metallic DES that have a matrix coating of bioresorbable polymer and antiproliferative drug. These devices, which have typical metallic nondegradable stent backbones, are known as bioresorbable polymer DES, bioabsorbable polymer DES or biodegradable polymer DES. Therefore, this report concentrates only on the BDS market for fully bioabsorbable or biodegradable stents.

The only applications of the biodegradable stent market that have been analyzed in this report includes
  • BDS for vascular disease.
  • Coronary BDS.
  • Non-coronary vascular BDS.
  • BDS for non-vascular disease.
  • Ureteral.
  • Gastrointestinal.
  • Biliary.
  • Pancreatic.
  • Others.
The report also offers a detailed patent analysis with information on the strategic initiatives of market players within the past five years.

The report specifically excludes stents that are not fully biodegradable and also stents that have bioabsorbable coatings which are not fully bioabsorbable. The report also excludes biomaterial technology/product and equipment providers.

Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc.
  • Amg International Gmbh
  • Boston Scientific Corp.
  • Ella-Cs S.R.O.
  • Lifetech Scientific Corp.
  • Micell Technologies Inc.
  • MORE
Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports
Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background
  • Technology Overview
  • Unmet Needs of Current Metallic DES
  • Very Late Stent Thrombosis and Restenosis
  • Implications of the Removal of a Permanent Implant
  • Technology Background
  • Technological Advantages of Biodegradable Stents
  • Technological Disadvantages
  • BDS Material Platform and Classification
  • Polymeric Biodegradable Stents
  • Metallic Biodegradable Stents
  • Market Regulation
  • Key Drivers
  • Growing Cardiovascular Intervention Market
  • Aging Populations
  • Emerging Middle Class
  • Increased Health Awareness
  • Key Challenges
  • Regulatory Issues
  • High Cost of Products/Procedure
  • Safety Issues
  • Visualization of the Scaffold for Implantation
  • Scaffold Deliverability
  • Scaffold Implantation
  • Radial Strength
  • Low Ductility
  • Market Trends
Chapter 4 Market Breakdown by Application Type
  • Biodegradable Vascular Stents (BVS)
  • Biodegradable Stents for Coronary Disease
  • Biodegradable Stents for Non-coronary Vascular Disease
  • BDS for Non-vascular Disease
  • Ureteral Stents
  • Gastrointestinal Stents
  • Bile Duct/Pancreatic Stents
  • Tracheobronchial/Pulmonary Stents
Chapter 5 Market Breakdown by Region
  • North America
  • U.S.
  • APAC
  • India
  • China
  • European Union
  • ROW
  • Brazil
Chapter 6 Patent Review
  • Patent Review by Year
  • Patent Review by Country
  • Patent Review by Assignee
  • Patent Review by Application
Chapter 7 Company Profiles
  • Abbott Vascular Inc.
  • Akina Inc.
  • Amaranth Medical Inc.
  • AMG International Gmbh
  • Arterial Remodeling Technologies S.A. (Art)
  • Arterius Ltd.
  • Biotronik Inc.
  • Boston Scientific Corp.
  • Cardionovum Gmbh
  • Elixir Medical Corp.
  • Ella-Cs S.R.O.
  • Endocor Gmbh
  • Hydrustent
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Lifetech Scientific Corp.
  • Lyra Therapeutics
  • Meril Life Sciences
  • Micell Technologies Inc.
  • Microport Scientific Corp.
  • Reva Medical Inc.
  • S3V Vascular Technologies
  • Sahajanand Medical Technologies (Smt)
  • Sino Medical Sciences Technology Inc. (Sinomed)
  • Stentys S.A.
  • Tepha Inc.
  • Terumo Cardiovascular Systems Corp.
  • Zorion Medical Inc.
Chapter 8 Appendix
  • Acronyms
  • Glossary
  • Countries That Require CE Marking
List of Tables
Summary Table: Global Market for Biodegradable Stents, by Region, Through 2023
Table 1: Properties of Biodegradable Materials Commonly Used in Biodegradable Stents
Table 2: Global Market for Biodegradable Stents for Vascular and Non-vascular Disease, Through 2023
Table 3: Global Market for Biodegradable Vascular Stents, Through 2023
Table 4: Global Market for Biodegradable Stents for Coronary and Non-coronary Vascular Disease, Through 2023
Table 5: Global Market for Biodegradable Stents for Coronary Disease, Through 2023
Table 6: CE-Marking-Approved Bioresorbable Scaffolds
Table 7: Global Market for Biodegradable Stents for Coronary Disease, by Region, Through 2023
Table 8: Other Biodegradable Stents in R&D
Table 9: Global Market for Biodegradable Stents for Non-coronary Vascular Disease, Through 2023
Table 10: Global Market for Biodegradable Stents for Non-coronary Vascular Disease, by Region, Through 2023
Table 11: Global Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
Table 12: Global Market for Biodegradable Stents for Peripheral Vascular Disease, by Type, Through 2023
Table 13: Global Market for Biodegradable Stents for Non-vascular Disease, Through 2023
Table 14: Global Market for Biodegradable Stents for Non-vascular Disease, by Region, Through 2023
Table 15: Global Market for Biodegradable Ureteral Stents, Through 2023
Table 16: Global Market for Gastrointestinal Biodegradable Stents, Through 2023
Table 17: Global Market for Biliary/Pancreatic Biodegradable Stents, Through 2023
Table 18: Global Market for Biodegradable Stents, by Region, Through 2023
Table 19: North American Market for Biodegradable Stents, Through 2023
Table 20: North American Market for Biodegradable Stents for Vascular Disease, Through 2023
Table 21: U.S. Market for Biodegradable Stents, Through 2023
Table 22: U.S. Market for Biodegradable Stents for Vascular Disease, Through 2023
Table 23: U.S. Market for Biodegradable Stents for Coronary Disease, Through 2023
Table 24: U.S. Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
Table 25: U.S. Market for Biodegradable Stents for Other Non-coronary Vascular (Carotid) Diseases, Through 2023
Table 26: U.S. Market for Biodegradable Stents for Non-vascular Disease, Through 2023
Table 27: APAC Market for Biodegradable Stents, Through 2023
Table 28: APAC Market for Biodegradable Stents for Coronary Disease, Through 2023
Table 29: APAC Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
Table 30: APAC Market for Biodegradable Stents for Other Non-coronary Vascular (Carotid) Diseases, Through 2023
Table 31: APAC Market for Biodegradable Stents for Vascular Disease, Through 2023
Table 32: APAC Market for Biodegradable Stents for Non-vascular Disease, Through 2023
Table 33: Indian Market for Biodegradable Stents, Through 2023
Table 34: Number of Coronary Stents Implanted in India, Through 2017
Table 35: European Union Market for Biodegradable Stents, Through 2023
Table 36: European Union Market for Biodegradable Stents for Coronary Disease, Through 2023
Table 37: European Union Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
Table 38: European Union Market for Biodegradable Stents for Non-coronary Vascular Disease, Through 2023
Table 39: European Union Market for Biodegradable Stents for Vascular Disease, Through 2023
Table 40: European Union Market for Biodegradable Stents for Non-vascular Disease, Through 2023
Table 41: ROW Market for Biodegradable Stents, Through 2023
Table 42: ROW Market for Coronary Biodegradable Stents, Through 2023
Table 43: ROW Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
Table 44: ROW Market for Biodegradable Stents for Non-coronary Vascular Disease, Through 2023
Table 45: ROW Market for Biodegradable Stents for Vascular Disease, Through 2023
Table 46: ROW Market for Biodegradable Stents for Non-vascular Disease, Through 2023
Table 47: ROW Market for Biodegradable Stents, by Country, Through 2023
Table 48: Patents and Patent Applications on Biodegradable Stents, Through 2018
Table 49: Abbott Laboratories: Company Financials, Through 2017
Table 50: Boston Scientific Corp.: Company Financials, Through 2017
Table 51: Lepu Medical Corp.: Company Financials, Through 2017
Table 52: Lifetech Scientific Corp.: Company Financials, Through 2017
Table 53: Microport Scientific Corp.: Company Financials, Through 2017
Table 54: Stentys S.A.: Company Financials, Through 2017
Table 55: Acronyms Used in the Biodegradable Stents Industry
Table 56: Glossary of Terms Used in the Biodegradable Stents Industry

List of Figures
Summary Figure: Global Market for Biodegradable Stents, by Region, 2016-2023
Figure 1: Global Market Shares of Biomaterials Used in Biodegradable Stents, by Type, 2016
Figure 2: Global Market Shares of Biomaterials Used in Biodegradable Stents, by Type of Material, 2023
Figure 3: Global Market for Biodegradable Stents for Cardiovascular Disease, by Region, 2018-2023
Figure 4: Forecast Global Population Share, by Age Group, 2050
Figure 5: Global Market Shares of Biodegradable Stents for Vascular and Non-vascular Disease, 2018
Figure 6: Global Market Shares of Biodegradable Stents for Vascular and Non-vascular Disease, 2023
Figure 7: Global Market Shares of Biodegradable Stents for Coronary and Non-coronary Vascular Disease, 2018
Figure 8: Global Market Shares of Biodegradable Stents Coronary and Non-coronary Vascular Disease, 2023
Figure 9: Global Market Penetration of Biodegradable Stents for Peripheral Vascular Disease, by Type, 2016-2023
Figure 10: Global Market Shares of Biodegradable Stents for Peripheral Vascular Disease, by Type, 2023
Figure 11: Global Market Shares of Biodegradable Stents for Non-vascular Disease, by Type, 2018
Figure 12: Global Market Shares of Biodegradable Stents for Non-vascular Disease, by Type, 2023
Figure 13: Global Market Shares of Biodegradable Stents, by Region, 2018
Figure 14: Global Market Shares of Biodegradable Stents, by Region, 2023
Figure 15: North American Market Shares of Biodegradable Stents, by Application, 2023
Figure 16: APAC Market Shares of Biodegradable Stents, by Application, 2023
Figure 17: Indian Market Volume Shares of Stents, by Type, 2016
Figure 18: European Union Market Shares of Biodegradable Stents, by Disease Application, 2023
Figure 19: ROW Market Shares of Biodegradable Stents, by Application, 2023
Figure 20: Number of Patents on Biodegradable Stents, 2012-2017
Figure 21: Global Market Shares of Patents on Biodegradable Stents, by Country, 2012-2017
Figure 22: Global Patents on Biodegradable Stents Published by Top Patents Offices, 2015-2017
Figure 23: Patents Granted to Assignees with at Least Five Patents on Biodegradable Stents, 2012-2017
Figure 24: Global Market Shares of Patents on Biodegradable Stents, by Application, 2012-2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Vascular Inc.
  • Akina Inc.
  • Amaranth Medical Inc.
  • Amg International Gmbh
  • Arterial Remodeling Technologies S.A. (Art)
  • Arterius Ltd.
  • Biotronik Inc.
  • Boston Scientific Corp.
  • Cardionovum Gmbh
  • Elixir Medical Corp.
  • Ella-Cs S.R.O.
  • Endocor Gmbh
  • Hydrustent
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Lifetech Scientific Corp.
  • Lyra Therapeutics
  • Meril Life Sciences
  • Micell Technologies Inc.
  • Microport Scientific Corp.
  • Reva Medical Inc.
  • S3V Vascular Technologies
  • Sahajanand Medical Technologies (Smt)
  • Sino Medical Sciences Technology Inc. (Sinomed)
  • Stentys S.A.
  • Tepha Inc.
  • Terumo Cardiovascular Systems Corp.
  • Zorion Medical Inc.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4761513
Adroll
adroll